
Thursday, June 06, 2019 12:12:34 PM
They figured out the manufacturing side of the equation very early on. That was one of the very first assignments.
Arch has not been close to commercialization in the past four years.
Corporate Presentation
https://content.equisolve.net/archtherapeutics/media/c6dc3c52a4e0458fae43779086460ea0.pdf
Recent ARTH News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2025 09:00:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2025 09:30:29 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 12/31/2024 09:15:29 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/13/2024 10:18:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 09:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 09:00:11 PM
UAV Corp. to Present Critical Inflation Test in 30 Days, Paving the Way to Secure Over $525 Million in DART Series Sales Contracts • UMAV • Mar 14, 2025 1:00 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM
The Crypto Company Expands Leadership Team With Experienced Financial and Blockchain Professionals • CRCW • Mar 13, 2025 9:23 AM
ConnectM Announces $10 Million Share Repurchase Program • CNTM • Mar 13, 2025 9:13 AM
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making • SIGY • Mar 12, 2025 9:41 AM